Cilag (Pevaryl Brand Portfolio European Rights) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Cilag (Pevaryl Brand Portfolio European Rights) General Information
Description
Antifungal medication brand portfolio Pevaryl in Europe.
Contact Information
Corporate Office
- Switzerland
Corporate Office
- Switzerland
Cilag (Pevaryl Brand Portfolio European Rights) Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Cilag (Pevaryl Brand Portfolio European Rights) Patents
Cilag (Pevaryl Brand Portfolio European Rights) Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
DE-1700122-U | Rubber by puncturing closure for infusion. | Inactive | 19-Jun-1954 |
Cilag (Pevaryl Brand Portfolio European Rights) Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Cilag (Pevaryl Brand Portfolio European Rights) FAQs
-
Where is Cilag (Pevaryl Brand Portfolio European Rights) headquartered?
Cilag (Pevaryl Brand Portfolio European Rights) is headquartered in Switzerland.
-
What industry is Cilag (Pevaryl Brand Portfolio European Rights) in?
Cilag (Pevaryl Brand Portfolio European Rights)’s primary industry is Buildings and Property.
-
Is Cilag (Pevaryl Brand Portfolio European Rights) a private or public company?
Cilag (Pevaryl Brand Portfolio European Rights) is a Private company.
-
What is the current valuation of Cilag (Pevaryl Brand Portfolio European Rights)?
The current valuation of Cilag (Pevaryl Brand Portfolio European Rights) is
. -
What is Cilag (Pevaryl Brand Portfolio European Rights)’s current revenue?
The current revenue for Cilag (Pevaryl Brand Portfolio European Rights) is
. -
Who are Cilag (Pevaryl Brand Portfolio European Rights)’s investors?
Cilag has invested in Cilag (Pevaryl Brand Portfolio European Rights).
-
When was Cilag (Pevaryl Brand Portfolio European Rights) acquired?
Cilag (Pevaryl Brand Portfolio European Rights) was acquired on 08-May-2020.
-
Who acquired Cilag (Pevaryl Brand Portfolio European Rights)?
Cilag (Pevaryl Brand Portfolio European Rights) was acquired by Karo Healthcare.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »